What AI says about InClinico

inClinico is a data-driven, multimodal AI platform by pharma.ai that forecasts the probability of success (PoS) for individual clinical trials using extensive preclinical and clinical data on targets, diseases, trials, and scientists. It scores and optimizes trial designs, performs clinical risk assessment and portfolio triage, and provides comprehensive reports and post-mortem analyses to guide investment, licensing, and development decisions. The platform combines proprietary ML models, advanced NLP, and harmonized public data from OMICs, publications, grants, patents, trials, and drugs to simulate alternative designs and quantify the influence of each feature on PoS.